Literature DB >> 10839340

Prepulse inhibition of the startle response in men with schizophrenia: effects of age of onset of illness, symptoms, and medication.

V Kumari1, W Soni, V M Mathew, T Sharma.   

Abstract

BACKGROUND: Prepulse inhibition of the startle reflex response refers to the ability of a weak prestimulus to transiently inhibit the response to a closely following strong sensory stimulus. This effect represents an operational index of sensorimotor gating and is found to be deficient in schizophrenia. Prepulse inhibition deficits in schizophrenia seem to be partially normalized by typical antipsychotics and more fully by some atypical antipsychotics. Early onset of schizophrenia, particularly in men, has been associated with abnormal brain maturation, profound neuropsychological deficits, and less responsiveness to antipsychotic medication. We evaluated the effects of the age of onset of illness, current positive and negative symptoms, and the type of medication (typical vs atypical) on prepulse inhibition of the startle response in schizophrenia.
METHODS: Thirty-eight male schizophrenic patients and 20 healthy male controls underwent testing for prepulse inhibition of the acoustic startle response.
RESULTS: Earlier onset of illness was associated with reduced prepulse inhibition, while adult onset of illness was not. No significant relationships occurred between current symptoms and prepulse inhibition. Patients given typical, but not atypical, antipsychotics exhibited less prepulse inhibition compared with healthy controls.
CONCLUSION: Early onset of illness is associated with profound deficits in prepulse inhibition of the startle response in men with schizophrenia.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10839340     DOI: 10.1001/archpsyc.57.6.609

Source DB:  PubMed          Journal:  Arch Gen Psychiatry        ISSN: 0003-990X


  54 in total

Review 1.  Impact of TCF4 on the genetics of schizophrenia.

Authors:  Leonhard Lennertz; Boris B Quednow; Jens Benninghoff; Michael Wagner; Wolfgang Maier; Rainald Mössner
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2011-09-20       Impact factor: 5.270

Review 2.  Insights and treatment options for psychiatric disorders guided by functional MRI.

Authors:  Tonmoy Sharma
Journal:  J Clin Invest       Date:  2003-07       Impact factor: 14.808

3.  Effect of adrenalectomy and corticosterone replacement on prepulse inhibition and locomotor activity in mice.

Authors:  Maarten van den Buuse; Margaret Morris; Carolina Chavez; Sally Martin; JianHong Wang
Journal:  Br J Pharmacol       Date:  2004-05-17       Impact factor: 8.739

4.  Psilocybin-induced deficits in automatic and controlled inhibition are attenuated by ketanserin in healthy human volunteers.

Authors:  Boris B Quednow; Michael Kometer; Mark A Geyer; Franz X Vollenweider
Journal:  Neuropsychopharmacology       Date:  2011-09-28       Impact factor: 7.853

5.  Two quantitative trait loci for prepulse inhibition of startle identified on mouse chromosome 16 using chromosome substitution strains.

Authors:  Tracey L Petryshen; Andrew Kirby; Ronald P Hammer; Shaun Purcell; Sinead B O'Leary; Jonathan B Singer; Annie E Hill; Joseph H Nadeau; Mark J Daly; Pamela Sklar
Journal:  Genetics       Date:  2005-07-05       Impact factor: 4.562

Review 6.  Endophenotypes in schizophrenia: a selective review.

Authors:  Allyssa J Allen; Mélina E Griss; Bradley S Folley; Keith A Hawkins; Godfrey D Pearlson
Journal:  Schizophr Res       Date:  2009-02-15       Impact factor: 4.939

7.  Interaction between the effects of corticotropin-releasing factor and prepulse parameters on prepulse inhibition in two inbred rat strains and the F1 generation of a cross between them.

Authors:  Lisa H Conti; Jane E Sutherland; Carey M Muhlhauser
Journal:  Behav Brain Res       Date:  2009-06-08       Impact factor: 3.332

8.  Deficit in prepulse inhibition in mice caused by dietary n-3 fatty acid deficiency.

Authors:  Irina Fedorova; Anita R Alvheim; Nahed Hussein; Norman Salem
Journal:  Behav Neurosci       Date:  2009-12       Impact factor: 1.912

9.  Effects of acute treatment with antidepressant drugs on sensorimotor gating deficits in rats.

Authors:  B Pouzet; M Paabøl Andersen; S Hogg
Journal:  Psychopharmacology (Berl)       Date:  2004-08-27       Impact factor: 4.530

Review 10.  Neurocognitive, Neuroprotective, and Cardiometabolic Effects of Raloxifene: Potential for Improving Therapeutic Outcomes in Schizophrenia.

Authors:  Mohammad M Khan
Journal:  CNS Drugs       Date:  2016-07       Impact factor: 5.749

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.